- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03912922
SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism? (SITLESS4)
SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism? A Study to Identify Underlying Mechanisms
Research has shown that replacing sitting time with low intensity physical activity (such as slowly walking and standing) has beneficial effects on metabolic health, like insulin sensitivity, comparable to improvements after sitting all day in combination with 1h streneous exercise.
The main objective of this study is to investigate the underlying mechanisms responsible for improved insulin sensitivity after 4 days of sitting less compared to sitting and exercise in healthy obese women. Our secondary objective is to investigate the effects of sitting less on cardio metabolic parameters.
Studieöversikt
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Maastricht, Nederländerna
- Maastricht University Medical Centre
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Signed informed consent
- Caucasian
- Postmenopausal women
- Aged 45-70 years at start of the study
- Body mass index (BMI) 25 - 35 kg/m2
- Stable dietary habits (no weight loss or gain >5kg in the past 3 months)
- Sedentary lifestyle (not more than 2,5 hours of exercise per week in the past 3 months)
Exclusion Criteria:
- Not able to complete the sitless try-out day according to the protocol
- Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other)
- No use of medication interfering with investigated study parameters (as determined by responsible physician)
- Alcohol consumption of >2 servings per day
- Smoking in the past 6 months
- Participation in another biomedical trial which may have an effect on insulin sensitivity less than one month before the start of the study (screening visit)
- Mental or physical disability which interferes with physical activity
- Subjects with contra-indications for magnetic resonance imaging (MRI)
- Reported participation in night shift work 2 weeks prior to the start of the study (screening visit) and during study participation. Night work is defined as working between midnight and 6.00 AM.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Sit regime
Subjects will follow the sit regime during four days.
Each day consists of 14 hours sitting, 1 hour walking and 1 hour standing and 8 hours sleeping.
|
Activity regime of 4 days followed by a test day.
|
|
Experimentell: Sit less regime
Subjects will follow the sit less regime during four days.
Each day will consist of 9 hours sitting, 3 hours walking, 4 hours standing and 8 hours sleeping.
|
Activity regime of 4 days followed by a test day.
|
|
Experimentell: Exercise regime
Subjects will follow the exercise regime during four days.
Each day will consist of 13 hours sitting, 1 hour walking, 1 hour standing, 1 hour exercise and 8 hours sleeping.
The cycle session will be at approximately 60% maximal power.
Exact cycling intensity and duration will be calculated to ensure equal total energy expenditure between the sitting less and the exercise regime.
|
Activity regime of 4 days followed by a test day.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Insulin sensitivity
Tidsram: Day 5 of intervention period
|
2-step hyperinsulinemic euglycemic clamp
|
Day 5 of intervention period
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
ex vivo skeletal muscle mitochondrial respiration
Tidsram: Day 5 of intervention period
|
oxygraph
|
Day 5 of intervention period
|
|
substrate oxidation
Tidsram: Day 5 of intervention period
|
indirect calorimetry RER
|
Day 5 of intervention period
|
|
Intrahepatic lipid content
Tidsram: Day 5 of intervention period
|
magnetic resonance spectroscopy
|
Day 5 of intervention period
|
|
Blood pressure
Tidsram: Day 5 of intervention period
|
average resting blood pressure over 30 minutes
|
Day 5 of intervention period
|
|
Plasma cardio metabolic markers
Tidsram: Day 5 of intervention period
|
endothelial dysfunction score (average Z-score of log transformed plasma sVCAM1, sICAM1 and sE-selectin)
|
Day 5 of intervention period
|
Samarbetspartners och utredare
Samarbetspartners
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- NL62413.068.17
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .